Protamine sulfate enhances lipid-mediated gene transfer (original) (raw)

Gene Therapy volume 4, pages 961–968 (1997)Cite this article

Abstract

A polycationic peptide, protamine sulfate, USP, has been shown to be able to condense plasmid DNA efficiently for delivery into several different types of cells in vitro by several different types of cationic liposomes. The monovalent cationic liposomal formulations (DC-Chol and lipofectin) exhibited increased transfection activities comparable to that seen with the multivalent cationic liposome formulation, lipofectamine. This suggests that lipofectamine’s superior in vitro activity arises from its ability to condense DNA efficiently and that protamine’s primary role is that of a condensation agent, although it also possesses several amino acid sequences resembling that of a nuclear localization signal. While the use of polycations to condense DNA has been previously reported, the use of protamine sulfate, USP as a condensation agent was found to be superior to poly- L-lysine as well as to various other types of protamine. These differences among various salt forms of protamine appear to be attributable to structural differences between the protamines and not due to differences in the net charge of the molecule. The appearance of lysine residues within the protamine molecule correlate with a reduction in binding affinity to plasmid DNA, as well as an observed loss in transfection-enhancing activity. This finding sheds light on the structural requirements of condensation agents for use in gene transfer protocols. Furthermore, protamine sulfate, USP is an FDA-approved compound with a documented safety profile and could be readily used as an adjuvant to a human gene therapy protocol.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 6 print issues and online access

$259.00 per year

only $43.17 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Author information

Author notes

  1. FL Sorgi
    Present address: Advanced Therapies, Inc, 371 Bel Marin Keys Blvd, Suite 210, Novato, 94949, CA, USA

Authors and Affiliations

  1. Department of Pharmacology, The Laboratory of Drug Targeting, The University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
    FL Sorgi, S Bhattacharya & L Huang

Authors

  1. FL Sorgi
    You can also search for this author inPubMed Google Scholar
  2. S Bhattacharya
    You can also search for this author inPubMed Google Scholar
  3. L Huang
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Sorgi, F., Bhattacharya, S. & Huang, L. Protamine sulfate enhances lipid-mediated gene transfer.Gene Ther 4, 961–968 (1997). https://doi.org/10.1038/sj.gt.3300484

Download citation

Keywords